Substance | <15 | 15–19 | 20–24 | 25–29 | 30–34 | 35–39 | 40–44 | 45+ | Age known | Age not known |
---|---|---|---|---|---|---|---|---|---|---|
Opiates | 19.6 | 38.4 | 56.6 | 58.8 | 55.1 | 51.7 | 39.7 | 30.5 | 2742 | 220 |
Cocaine | 6.6 | 8.2 | 8.2 | 8.8 | 8.5 | 13.4 | 6.3 | 7.3 | 526 | 107 |
Stimulants | 11.9 | 22.4 | 15.6 | 11.5 | 7.9 | 8.7 | 6.3 | 7.3 | 1101 | 91 |
Hypnotics and sedatives | 1.6 | 2.1 | 3.4 | 5.9 | 11.1 | 9.4 | 27.0 | 45.1 | 262 | 168 |
Hallucinogens | 0.1 | 0.7 | 0.4 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 29 | 14 |
Volatile substances | 4.9 | 1.9 | 0.3 | 0.3 | 0.0 | 0.7 | 1.6 | 0.0 | 113 | 8 |
Cannabis | 52.9 | 22.9 | 9.0 | 6.5 | 4.9 | 6.7 | 12.7 | 1.2 | 1405 | 281 |
Other substances | 2.4 | 3.4 | 6.4 | 7.5 | 12.5 | 9.4 | 6.3 | 8.5 | 320 | 202 |
Total | 1026 | 2898 | 1349 | 626 | 305 | 149 | 63 | 82 | 6498 | 1091 |
The number of treatment clients in each country is listed in Table TDI-7.
See also Table TDI-108 on distribution by country and 'General notes for interpreting data’ on the Explanatory notes and help page.
Reitox national reports 2012 — Table TDI — outpatient treatment centres.